Phase 1 trial of poly (lactide-co-glycolide) (PLG) nanoparticles encapsulating antitubercular drugs (isoniazid, rifmapicin, pyrazinamide and ethambutol).
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Rifampicin/isoniazid/pyrazinamide/ethambutol (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 16 Nov 2016 New trial record